ATE123417T1 - Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung. - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.

Info

Publication number
ATE123417T1
ATE123417T1 AT90915171T AT90915171T ATE123417T1 AT E123417 T1 ATE123417 T1 AT E123417T1 AT 90915171 T AT90915171 T AT 90915171T AT 90915171 T AT90915171 T AT 90915171T AT E123417 T1 ATE123417 T1 AT E123417T1
Authority
AT
Austria
Prior art keywords
treatment
atopic dermatitis
pharmaceutical compositions
skin diseases
production
Prior art date
Application number
AT90915171T
Other languages
English (en)
Inventor
Janos Szabo
Laszlo Szalay
Laszlone Szalay
Original Assignee
Janos Szabo
Laszlo Szalay
Laszlone Szalay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU895239A external-priority patent/HU895239D0/hu
Priority claimed from HU895238A external-priority patent/HU213508B/hu
Application filed by Janos Szabo, Laszlo Szalay, Laszlone Szalay filed Critical Janos Szabo
Application granted granted Critical
Publication of ATE123417T1 publication Critical patent/ATE123417T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90915171T 1989-10-06 1990-10-05 Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung. ATE123417T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU895239A HU895239D0 (en) 1989-10-06 1989-10-06 Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
HU895238A HU213508B (en) 1989-10-06 1989-10-06 Process for producing pharmaceutical compositions for treating piogene and athopic leather diseases

Publications (1)

Publication Number Publication Date
ATE123417T1 true ATE123417T1 (de) 1995-06-15

Family

ID=26317824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915171T ATE123417T1 (de) 1989-10-06 1990-10-05 Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.

Country Status (6)

Country Link
EP (1) EP0450015B1 (de)
AT (1) ATE123417T1 (de)
DE (1) DE69019956T2 (de)
DK (1) DK0450015T3 (de)
ES (1) ES2075221T3 (de)
WO (1) WO1991004742A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098109C1 (ru) * 1996-09-26 1997-12-10 Александр Григорьевич Чучалин Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием
IN2012DN03418A (de) * 2009-10-09 2015-10-23 Childrens Medical Center
FR2969657B1 (fr) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
DK3492089T3 (da) * 2017-11-29 2021-04-12 Symbiogruppe Gmbh & Co Kg Dermatologisk sammensætning indeholdende Escherichia coli og Enterococcus faecalis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia

Also Published As

Publication number Publication date
EP0450015B1 (de) 1995-06-07
ES2075221T3 (es) 1995-10-01
WO1991004742A1 (en) 1991-04-18
EP0450015A1 (de) 1991-10-09
DE69019956D1 (de) 1995-07-13
DK0450015T3 (da) 1995-10-02
DE69019956T2 (de) 1995-11-23

Similar Documents

Publication Publication Date Title
NO942468D0 (no) Fremgangsmåte for fremstilling av 2-alkyl-3,4,6-trifluorbenzoesyre
AU724518B2 (en) Antiinfective free intramammary veterinary composition
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
GR1002451B (el) Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
CS149192A3 (en) Pharmaceutical composition, process of its preparation and method offungal infections treating
RU93004457A (ru) 1-карба-(1-детиа)-цефемы и промежуточные продукты для их получения
DE69019956D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.
US4364926A (en) Novel alkaline protease M3 method for the preparation thereof and dental caries-prophylactic composition containing the same
DE69227395D1 (de) Heparitinase, Verfahren zur Herstellung und Bakterie, die Heparitinase herstellt
GR3031078T3 (en) Antibacterial composition containing multimeric alpha-lactalbumin
FR2616693B1 (fr) Procede de fabrication d'articles a partir de produit divise
Ginsburg Streptococcus.
EP0269928A3 (de) Bakterielles antigenisches Lysat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die es enthalten
JP7629693B2 (ja) 抗菌剤
HUP0000146A2 (hu) Eljárás Streptococcus pneumoniae-fertőzés kezelésére
FR2307542A1 (fr) Nouvelle preparation immunostimulante
CN104231255A (zh) 松萝酸脂肪醇聚氧乙烯醚络合物
Ryan Streptococci.
Stubblefield et al. Reply to Dr. Corson
Usami et al. Study of organisms isolated from non-infected patients with pneumoconiosis
RU2079222C1 (ru) Способ получения лечебного продукта на основе молока
YU et al. Therapeutic Effect of Ornidazole on the Anaerobic Infections After Maxillofacial Plastic Surgery
CN1062269A (zh) 动物毛、角、蹄壳和鳞片的处理方法
Nador Meat inspectional importance of abscesses observed in swine. IV. Abscesses found in the tenderloin of pork.
Diachenko The patient's own staphylococcal strains of nasal origin as potential causative agents of inflammatory processes in the maxillofacial area

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee